We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLT icon
2401
Allot
ALLT
$362M
$1.08M ﹤0.01%
132,925
+65,557
+97% +$598K
SABSW icon
2402
CALL
SAB Biotherapeutics Warrant
SABSW
$92.9K
$1.07M ﹤0.01%
285,000
REVH
2403
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$1.07M ﹤0.01%
109,191
EBACW
2404
CALL
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
$1.06M ﹤0.01%
108,584
XLE icon
2405
State Street Energy Select Sector SPDR ETF
XLE
$39B
$1.06M ﹤0.01%
27,780
-27,072
-49% -$938K
PDSB icon
2406
PDS Biotechnology
PDSB
$37.4M
$1.06M ﹤0.01%
170,479
+101,550
+147% +$631K
ABVEW
2407
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$1.05M ﹤0.01%
107,213
NPTN
2408
DELISTED
NEOPHOTONICS CORP
NPTN
$1.05M ﹤0.01%
69,095
+569
+0.8% +$8.67K
HMLP
2409
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$1.05M ﹤0.01%
141,859
-1,014
-0.7% -$4.72K
KDNY
2410
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.04M ﹤0.01%
63,734
-123,293
-66% -$1.68M
AER icon
2411
AerCap
AER
$23.4B
$1.04M ﹤0.01%
20,679
+5,781
+39% +$347K
BRBR icon
2412
BellRing Brands
BRBR
$1.55B
$1.04M ﹤0.01%
45,000
-6,031
-12% -$151K
TSE
2413
DELISTED
Trinseo
TSE
$1.04M ﹤0.01%
+21,664
New +$1.14M
QSR icon
2414
Restaurant Brands International
QSR
$26.2B
$1.04M ﹤0.01%
+17,762
New +$1.01M
TCACW
2415
CALL
DELISTED
Tuatara Capital Acquisition Corporation Warrant
TCACW
$1.04M ﹤0.01%
105,000
VGASW icon
2416
CALL
Verde Clean Fuels Warrant
VGASW
$507K
$1.04M ﹤0.01%
103,668
ARBEW icon
2417
CALL
Arbe Robotics Warrant
ARBEW
$336K
$1.03M ﹤0.01%
148,742
-1,258
-0.8% -$1.28K
APPS icon
2418
Digital Turbine
APPS
$982M
$1.03M ﹤0.01%
23,532
+22,787
+3,059% +$1.03M
LBRDK icon
2419
Liberty Broadband Class C
LBRDK
$4.89B
$1.03M ﹤0.01%
7,613
+2,541
+50% +$370K
DMS.WS
2420
CALL
DELISTED
Digital Media Solutions, Inc. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
DMS.WS
$1.03M ﹤0.01%
282,736
-17,264
-6% -$6.05K
RNR icon
2421
RenaissanceRe
RNR
$13.8B
$1.03M ﹤0.01%
+6,483
New +$1.01M
RSX
2422
DELISTED
VanEck Russia ETF
RSX
$1.03M ﹤0.01%
182,043
-667,712
-79% -$11.3M
RMCOW icon
2423
CALL
Royalty Management Holding Warrant
RMCOW
$1.46M
$1.03M ﹤0.01%
100,000
UTI icon
2424
Universal Technical Institute
UTI
$2.26B
$1.03M ﹤0.01%
115,863
+43,352
+60% +$356K
LINC icon
2425
Lincoln Educational Services
LINC
$1.38B
$1.02M ﹤0.01%
142,360
+111,150
+356% +$805K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.